AlphaQuest LLC Acquires 10,606 Shares of Agilent Technologies, Inc. $A

Key Points

• AlphaQuest LLC increased its stake in Agilent Technologies by 98.2% during the 1st quarter, owning 21,401 shares valued at approximately $2.5 million.
• Agilent Technologies reported a 6.0% year-over-year revenue increase, with earnings per share of $1.31 for the last quarter, surpassing estimates by $0.05.
• Several analysts have set new target prices for Agilent Technologies, with estimates ranging from $125 to $150, indicating a generally positive outlook on the stock.

AlphaQuest LLC raised its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 98.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,401 shares of the medical research company's stock after purchasing an additional 10,606 shares during the quarter. AlphaQuest LLC's holdings in Agilent Technologies were worth $2,503,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of A. Brighton Jones LLC raised its stake in shares of Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after purchasing an additional 270 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Agilent Technologies by 4.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,150,499 shares of the medical research company's stock valued at $154,562,000 after purchasing an additional 49,833 shares during the period. TD Waterhouse Canada Inc. raised its stake in shares of Agilent Technologies by 48.7% in the 4th quarter. TD Waterhouse Canada Inc. now owns 443 shares of the medical research company's stock valued at $60,000 after purchasing an additional 145 shares during the period. OneDigital Investment Advisors LLC raised its stake in shares of Agilent Technologies by 10.7% in the 4th quarter. OneDigital Investment Advisors LLC now owns 6,728 shares of the medical research company's stock valued at $904,000 after purchasing an additional 648 shares during the period. Finally, IHT Wealth Management LLC raised its stake in shares of Agilent Technologies by 21.5% in the 4th quarter. IHT Wealth Management LLC now owns 1,919 shares of the medical research company's stock valued at $258,000 after purchasing an additional 339 shares during the period. Institutional investors and hedge funds own 87.41% of the company's stock.

Insider Buying and Selling

In related news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares in the company, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.26% of the company's stock.

Agilent Technologies Stock Down 0.6%

Shares of NYSE:A traded down $0.71 during midday trading on Tuesday, reaching $118.44. The company had a trading volume of 1,898,106 shares, compared to its average volume of 1,943,036. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. The business's 50 day moving average price is $117.88 and its 200 day moving average price is $116.87. The stock has a market cap of $33.64 billion, a PE ratio of 29.24, a P/E/G ratio of 3.69 and a beta of 1.22. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%.The business had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.63 billion. During the same quarter last year, the company posted $1.22 earnings per share. Agilent Technologies's quarterly revenue was up 6.0% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.540-5.610 EPS. Q3 2025 guidance at 1.350-1.370 EPS. Research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A has been the topic of several recent research reports. UBS Group dropped their price target on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research note on Thursday, May 29th. JPMorgan Chase & Co. dropped their price target on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research note on Thursday, May 29th. Wall Street Zen raised Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, June 28th. Robert W. Baird lowered their target price on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating on the stock in a research report on Thursday, May 22nd. Finally, Evercore ISI lifted their target price on Agilent Technologies from $125.00 to $130.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $138.83.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.